Alkermes PLC/ IE00B56GVS15 /
2024-09-20 10:00:00 PM | Chg. +0.2000 | Volume | Bid10:49:41 PM | Ask10:49:41 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
28.5500USD | +0.71% | 6.61 mill. Turnover: 151.52 mill. |
26.9900Bid Size: 100 | 29.3100Ask Size: 100 | 4.7 bill.USD | - | 13.34 |
GlobeNewswire
08-19
Fulcrum Therapeutics Strengthens Leadership Team with the Appointments of Isabel Kalofonos as Chief ...
GlobeNewswire
08-13
Mural Oncology Announces Second Quarter 2024 Financial Results and Provides Update on Pipeline Progr...
GlobeNewswire
03-26
Mural Oncology Announces Fourth Quarter and Year End 2023 Financial Results and Provides Business Up...
GlobeNewswire
2023-12-04
Atossa Therapeutics Announces the Appointment of Arezoo Mirad, M.D., as Senior Medical Director
GlobeNewswire
2023-11-15
Mural Oncology Launches to Advance Pipeline of Novel Engineered Cytokine Immunotherapies
GlobeNewswire
2023-09-11
Eledon Pharmaceuticals Appoints Industry Veteran James Robinson to its Board of Directors
GlobeNewswire
2022-03-28
Tango Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Provides Business...
Newsfile Corp
2022-03-15
Awakn Life Sciences Appoints Kevin Lorenz as U.S. Head of Commercial Development
GlobeNewswire
2022-03-15
Cogent Biosciences Provides Corporate Updates, Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2022-03-08
Baudax Bio Initiates Phase IV Clinical Trial Evaluating ANJESO® in Pediatric Patients Following Surg...
GlobeNewswire
2022-01-24
Tango Therapeutics Announces Clearance of TNG908 IND by FDA and Recent Pipeline Progress Updates
GlobeNewswire
2021-12-06
AGTC Appoints Biopharmaceutical Industry Leader James Robinson to its Board of Directors
GlobeNewswire
2021-11-04
Baudax Bio Reports Third Quarter 2021 Financial Results and Business Highlights
GlobeNewswire
2021-09-08
Finch Therapeutics Announces the Appointment of Marc Blaustein as Chief Operating Officer